Investigating the acceptability of remotely monitoring the vital signs of hospital-in-the-home patients using wearable devices, from the perspective of the patients, clinicians and administrators.

Not Applicable

• Conditions: Deterioration among hospital-in-the-home patients; Public Health - Health service research

• Registration Number: ACTRN12623000018617
• Lead Sponsor: Silver Chain Group Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-10
• Last Update Posted: 16 January 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

i.Aged between 40 – 60 years, and
ii.Enrolled in (or about to be enrolled in) Silver Chain's 'hospital in the home' (HITH)/'hospital at the home' (HATH) programs, and
iii.Possess a sufficient English proficiency to understand the Participant Information and Consent Form (PICF) without requiring a translator.

Exclusion Criteria

i.Do not speak English/requires a translator.
ii.Possess a significant cognitive impairment or psychological illness (e.g. dementia) that would inhibit participation (as determined by a Silver Chain clinician).
iii.Are receiving palliative care.
iv.Are considered to be a 'high severity' patient:
a.Is immunocompromised
b.Is unable to manage pain with simple analgesics
c.Currently has/previously had diabetic foot ulcers
d.Currently identified as obese
e.Currently prescribed multiple courses of intravenous antibiotics.
v.Are considered to be a 'high bleeding risk' patient:
a.Recent (within the last 4 weeks) major bleed
b.Recent (within the last 2 weeks) major surgery
c.Thrombocytopaenia (platelet count < 50 x 109L)
d.Known liver disease
e.Concurrent antiplatelet therapy
f.Risk of septic shock (fever > 38.5°C; Systolic BP < 90mmHg; HR > 100/min).

Study & Design

• Study Type: Interventional
• Study Design: Not specified